With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.21655-48-1,cis-2,6-Dimethylpiperazine,as a common compound, the synthetic route is as follows.
Description 4; Methyl-3-(4-{[(3R,5S)-3,5-dimethyl-1-piperazinyl]methyl}phenyl)-2-pyridine carboxylate (D4); To a solution of D3 (260 mg, 1.08 mmol) in dry DCM (30 ml) was added (2R,6S)-dimethylpiperazine (185 mg, 1.62 mmol) at 0° C. under argon. The reaction mixture was then warmed to 25° C. and stirred for 1 h. After this period, sodium (triacetoxy)borohydride (343 mg, 1.62 mmol) was added portionwise and the reaction mixture stirred at 25° C. under argon for 18 h. The reaction was then quenched with saturated NaHCO3 solution (50 ml) and extracted with DCM (3.x.50 ml). The organic layers were combined, washed with water, dried (Na2SO4) and concentrated in vacuo. The crude oil was purified by column chromatography on silica eluting with a 0-10percent [(9:1)MeOH:ammonia]/EtOAc gradient to afford the title compound (213 mg, 58percent). deltaH (CDCl3, 250 MHz) 1.04 (6H, d), 1.64 (2H, t), 2.79 (2H, m), 2.89-2.99 (2H, m), 3.54 (2H, s), 3.79 (3H, s), 7.28-7.50 (5H, m), 7.77 (1H, dd), 8.66 (1H, dd). MS (ES): C20H25N3O2 requires 339. found 340 (MH+), 21655-48-1
The synthetic route of 21655-48-1 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; Glaxo Group Limited; US2008/312209; (2008); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics